Overall verdict
Neutral
5.9/10
1-year performance
+14.00%
Score breakdown
Up 14.0% over 1 year, 89% of the 52-week range.
Strongest: Financial strength 9.6/10. Weakest: Profitability 5.2/10.
17 analysts, target -0.0% vs the price.
CME Group Inc., together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, and foreign exchange; and agricultural, energy, and metals commodities, as well as fixed income and foreign currency trading services. The company provides clearing house services, including clearing, settling, and guaranteeing futures and options contracts, and cleared swaps products traded through its exchanges.
In addition, the company offers a range of market data services, including real-time and historical data services. It serves professional traders, financial institutions, institutional and individual investors, corporations, manufacturers, producers, governments, and central banks. CME Group Inc. partners with FutureSports to futures on sports indexes.
The company was formerly known as Chicago Mercantile Exchange Holdings Inc. and changed its name to CME Group Inc. in July 2007. The company was founded in 1898 and is headquartered in Chicago, Illinois.
Sector
Financials
Industry
Capital Markets
Primary listing
Nasdaq
United States
CEO
Terrence Duffy
Founded
1898
Employees
3 875
Revenue / employee
1.7M USD
Next earnings
February 10, 2027 (estimated)
Institutional holders
- GEODE CAPITAL MANAGEMENT, LLC2.62%
- Bank of New York Mellon Corp0.82%
- FMR LLC0.38%
- Rest of the register96.17%
3 13F filings as of September 30, 2026: US managers above $100M, filed up to 45 days after quarter end. No insiders, no retail. A share on loan is declared by its lender and by whoever bought it from the short seller, so the total can exceed 100%.
Research uses the underlying stock’s market history. The purchase quote is calculated separately when you review your order.
52-week high
329.16 USD
52-week low
218.31 USD
1-year performance
14.00%
Rising
Year-to-date performance
16.48%
Rising
Drawdown
-3.66%
Near its high
Position in the 52-week range
89% of range
Against the world ETF
Over 24 years, from December 2002 to October 2026, the share did not clearly beat the world ETF once risk is accounted for. It earned much more, but shaking 2.1 times harder: once that risk is counted, it did about as well as the ETF.
$10,000 placed at the end of December 2002 are worth today
| CME Group | $732,083 |
| World ETF | $96,252 |
| S&P 500 | $131,807 |
| Risk-free placement | $15,121 |
The risk
- Shaking:the share moves 2.1 times as much as the world ETF.
- Worst fall:-74Â % between December 2007 and January 2009. $10,000 placed at the top fell to $2,605. The world ETF, at worst: -53Â %. Back to its high in 90 months.
CME Group earned 8 times as much as the world ETF since 2002
Value of $10,000 placed at the end of December 2002, dividends reinvested, in dollars
- CME Group: $732,083
- World ETF: $96,252
- S&P 500: $131,807
- Risk-free placement: $15,121
Based on past performance. This is not a recommendation.
Range: 227.00 USD - 287.52 USD (3 methods agree)
The price implies growth of 8.52% per year; the company grows at 13.70%.
Gross margin 82.8%, net margin 63.4%, ROIC 14.2%, ROE 16.1%.
Net margin
63.40%
Exceptional
Sector 28.46%|S&P 13.40%
Gross margin
82.76%
Fair
Return on equity (ROE)
16.15%
Fair
Sector 20.23%|S&P 17.06%
Return on invested capital (ROIC)
14.20%
Fair
Free cash flow margin (FCF)
62.15%
Exceptional
Profit-to-cash conversion (FCF conversion)
0.98x
Fair
Margin stability
19.3 pts
Very uneven
Revenue to net income
Growth
6.2/10Revenue up 13.0% over 1 year, 6.0% a year over 5, EPS 13.7% a year over 5.
Revenue (trailing 12 months)
7.0Md USD
Revenue growth (1y)
12.99%
Strong
Revenue growth (3y)
29.91%
Solid
EPS growth (1y)
16.22%
Hyper-growth
EPS CAGR (5y)
13.70%
Fair
EPS revisions (3 months)
1.05%
Revised up
Valuation
5.2/10P/E 26.0x, forward P/E 26.6x, EV/EBITDA 23.4x, PEG 1.90. The multiple sits in the 72th percentile of its own 5-year history.
P/E (TTM)
26.0x
Fair
Sector 24.4x|S&P 23.6x
Forward P/E
26.6x
Fair
EV / EBITDA
23.4x
Expensive
Sector 14.6x|S&P 15.5x
PEG
1.90
Expensive
Sector 0.50|S&P 0.91
Fair value (reverse DCF)
245.14 USD
Overvalued
P/E vs its own 5-year history
among the 28% highest valuations
Pricier than usual
Market cap
114Md USD
Financial strength
9.6/10Cash covers 60.6% of the debt, net debt/EBITDA -0.2x.
Net debt / EBITDA
-0.2x
Very solid
Gearing (net debt / equity)
5.72%
Very solid
Cash
2.3Md USD
Cash / market cap
2.06%
Stretched
Cash / total debt
60.55%
Very solid
Interest coverage
26.2x
Very solid
Net debt
1.5Md USD
Equity
26.6Md USD
Closed daily candles, 2 years
Last close on November 10, 2026: 309.09 USD
- MM20300.29
- MM50283.95
- MM200281.12
- RSI 1465.9
Top panel: closed candles, 20, 50 and 200-day moving averages, with volume in grey. Bottom panel: 14-day RSI with dashed 30 and 70 levels.
200-day average slope, 1 month
+0.94%
200-day average slope, 3 months
+0.98%
50-day average slope, 1 month
+4.40%
Price structure
higher-low
Bullish RSI divergence
No
20-day volatility
1.63 % per day
Volatility change
-1.91%
Forecasts by fiscal year
| Fiscal year | EPS | Normalised EPS | Revenue | EBITDA | Net income |
|---|---|---|---|---|---|
| 2026 | 11.94 (4) | 12.40 (17) | 7 088 (14) | 5 061 (9) | 4 389 (1) |
| 2027 | 12.99 (4) | 13.24 (17) | 7 469 (14) | 5 322 (9) | 4 643 (1) |
Amounts in millions of USD, EPS in USD per share. In brackets, the number of analysts. Consensus as of November 9, 2026.
Same sub-industry: 59 companies behind the medians.
| # | Company | Code | Country | Overall / 10 | Fundamentals / 10 | Mkt cap | P/E | Net margin | Revenue growth | ROIC | Net debt / EBITDA | FCF yield | 1-year perf. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 388 | 7.0 | 8.0 | 62.3Md USD | 24.5x | 62.0 % | 1.2 % | 35.5 % | -12.5x | — | -12.1 % | ||
| 2 | SPGI | 6.1 | 5.3 | 138Md USD | 28.3x | 31.7 % | 6.8 % | 13.3 % | 1.6x | 4.1 % | 1.5 % | ||
| 3 | LSEG | 6.0 | 5.6 | 59.6Md USD | 35.2x | 14.6 % | 5.0 % | 4.9 % | 1.7x | 8.4 % | 5.1 % | ||
| 4 | CME | 5.9 | 6.1 | 114Md USD | 26.0x | 63.4 % | 13.0 % | 14.2 % | -0.2x | 3.8 % | 14.0 % | ||
| 5 | DB1 | 5.9 | 5.6 | 63.2Md USD | 28.2x | 27.2 % | 149.8 % | 12.7 % | -2.8x | 5.3 % | 56.0 % | ||
| 6 | MCO | 5.8 | 5.8 | 88.8Md USD | 31.4x | 35.3 % | 0.8 % | 27.0 % | 1.2x | 3.4 % | 5.8 % | ||
| 7 | National Stock | 544937 | 5.8 | 4.7 | 50.9Md USD | — | — | 2.3 % | — | -4.3x | — | 10.5 % | |
| 8 | NDAQ | 5.6 | 4.8 | 60.9Md USD | 30.0x | 22.8 % | 20.9 % | 9.9 % | 2.8x | 3.7 % | 24.8 % | ||
| 9 | ICE | 5.5 | 5.0 | 101Md USD | 24.6x | 30.9 % | 11.3 % | 8.5 % | 2.7x | 5.2 % | 20.2 % |
